Norflex and Vaginal cancer - a phase IV clinical study of FDA data
We study 2,302 people who take Norflex or have Vaginal cancer. No report of Vaginal cancer is found in people who take Norflex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,831 Norflex users for its effectiveness, alternative drugs and more.
What is Vaginal Cancer?
Vaginal cancer is found to be associated with 358 drugs and 263 conditions by eHealthMe.
Do you take Norflex and have Vaginal cancer?Check whether Vaginal cancer is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Vaginal cancer and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,831 reports)
Vaginal cancer treatments and more:
- Vaginal cancer (471 reports)
COVID vaccines that are related to Vaginal cancer:
- Vaginal cancer in Moderna COVID Vaccine
- Vaginal cancer in Pfizer BioNTech Covid Vaccine
- Vaginal cancer in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Vaginal cancer:
All the conditions that are associated with Vaginal cancer:
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Myelosuppression and drugs of ingredients of n - acetyl cysteine - now
- Thiamine and Flank Pain - 2 seconds ago
- Nasonex and Excessive Or Unwanted Hair In Women - 2 seconds ago
- Cyclophosphamide and Stent - 5 seconds ago
- Theophylline and Candida Pneumonia - 5 seconds ago
- Abiraterone Acetate and Econazole Nitrate drug interaction - 6 seconds ago
- Ditropan and Sense Of Oppression - 7 seconds ago
- Lyrica and Benign Colonic Neoplasm - 11 seconds ago
- Belladonna and Atrioventricular Block First Degree - 24 seconds ago
- Depakote Cp vs. Inderal - 25 seconds ago